All In Biotech

Drug Trial Radar · NCT07054398

Assessment of Serum Catestatin Level in Acne Vulgaris Patients

Assessment of Serum Catestatin Level in Acne Vulgaris Patients Before and After Treatment With Oral Isotretinoin

Last checked: Nov 20, 2026Latest source record: Jul 8, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

60

Planned (sponsor's estimate)

Start

Jan 10, 2025

Primary completion

Jan 1, 2026

Study completion Jan 10, 2026

Sponsor

Lead sponsor
Aswan UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jul 8, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 40 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Acne vulgaris is a persistent inflammatory condition of the pilosebaceous unit, affecting 85% of people between the ages of 12 and 24, it is regarded as one of the most common diseases in teenagers and young adults. Catestatin, a peptide derived from chromogranin A (CgA), was first discovered in 1997 as an acute nicotinic-cholinergic antagonist. Later, it was determined that CST is a pleiotropic hormone.

Conditions

  • Acne Vulgaris

Interventions

  • IsotretinoinDrug

    * Measure the serum levels of catestatin in patients with moderate and severe acne vulgaris versus healthy control persons. * Evaluate the effect of oral isotretinoin treatment on serum catestatin levels in patients with moderate and severe acne vulgaris.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Evalaute serum level of Catestatin in acne patientTime frame: 12 weeks
  2. Evalaute the effect of treatment with systemic isotretinonTime frame: 12 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Aswan Unuversity Hospital

    Aswān, Egypt · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.